Literature DB >> 17698274

Anxiolytic-like effects of obovatol isolated from Magnolia obovata: involvement of GABA/benzodiazepine receptors complex.

Jeong-Ju Seo1, Seung-Ho Lee, Yong-Su Lee, Byoung-Mok Kwon, Yuan Ma, Bang-Yeon Hwang, Jin-Tae Hong, Ki-Wan Oh.   

Abstract

This experiment was performed to investigate whether obovatol isolated from the leaves of Magnolia obovata has anxiolytic-like effects through GABA-benzodiazepine-receptors Cl(-) channel activation. The anxiolytic-like effects of obovatol in mice were examined using the elevated plus-maze and the automatic hole-board apparatus. Oral administration of obovatol (0.2, 0.5 and 1.0 mg/kg) significantly increased the number of open arm entries and the spent time on open arm in the elevated plus-maze test, compared with those of saline. Obovatol (0.2, 0.5 and 1.0 mg/kg) also produced anxiolytic-like effects, as reflected by an increase in head-dipping behaviors. These effects were comparable to those of diazepam (1.0 mg/kg), a well known anxiolytic drug. On the other hand, the anxiolytic-like effects of obovatol and diazepam were reversed by flumazenil, a benzodiazepine receptor antagonist, suggesting that the anxiolytic-like effects of obovatol were involved in GABA-benzodiazepine receptors complex. Obovatol was muscle relaxant by rota-rod test, but its effect was weaker than diazepam. Spontaneous locomotor activity also was inhibited by obovatol. Obovatol selectively increased the GABA(A) receptors alpha(1) subunit expression in amygdala of mouse brain. Obovatol also showed to bind to benzodiazepine receptors competitively in experiments using [(3)H]flunitrazepam in the cerebral cortex of mouse brain. Moreover, obovatol (10, 20 and 50 microM) increased Cl(-) influx and the increased Cl(-) influx was inhibited by flumazenil, in primary cultured neuronal cells and IMR-32 human neuroblastoma cells. These results suggest that obovatol has anxiolytic-like effects, and these pharmacological effects may be mediated by GABA-benzodiazepine receptors-activated Cl(-) channel opening.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17698274     DOI: 10.1016/j.pnpbp.2007.05.009

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  11 in total

Review 1.  Chemical genetics of neuroinflammation: natural and synthetic compounds as microglial inhibitors.

Authors:  Kyoungho Suk; Jiyeon Ock
Journal:  Inflammopharmacology       Date:  2011-12-22       Impact factor: 4.473

2.  Neurite outgrowth effect of 4-O-methylhonokiol by induction of neurotrophic factors through ERK activation.

Authors:  Yong Kyoung Lee; Im Seop Choi; Young Heui Kim; Ki Ho Kim; Sang Yun Nam; Young Won Yun; Moon Soon Lee; Ki Wan Oh; Jin Tae Hong
Journal:  Neurochem Res       Date:  2009-12       Impact factor: 3.996

Review 3.  Plant-based medicines for anxiety disorders, Part 1: a review of preclinical studies.

Authors:  Jerome Sarris; Erica McIntyre; David A Camfield
Journal:  CNS Drugs       Date:  2013-03       Impact factor: 5.749

4.  Obovatol attenuates microglia-mediated neuroinflammation by modulating redox regulation.

Authors:  Jiyeon Ock; Hyung S Han; Su H Hong; So Y Lee; Young-Min Han; Byoung-Mog Kwon; Kyoungho Suk
Journal:  Br J Pharmacol       Date:  2010-04       Impact factor: 8.739

Review 5.  Sleep-Aids Derived from Natural Products.

Authors:  Zhenzhen Hu; Seikwan Oh; Tae-Woo Ha; Jin-Tae Hong; Ki-Wan Oh
Journal:  Biomol Ther (Seoul)       Date:  2018-07-01       Impact factor: 4.634

6.  Protective effect of the ethanol extract of Magnolia officinalis and 4-O-methylhonokiol on scopolamine-induced memory impairment and the inhibition of acetylcholinesterase activity.

Authors:  Yong Kyung Lee; Dong Yeon Yuk; Tae Il Kim; Young Heui Kim; Kyoung Tae Kim; Ki Ho Kim; Beom Jun Lee; Sang-Yoon Nam; Jin Tae Hong
Journal:  J Nat Med       Date:  2009-04-04       Impact factor: 2.343

7.  Extreme sensitivity of gene expression in human SH-SY5Y neurocytes to ultra-low doses of Gelsemium sempervirens.

Authors:  Marta Marzotto; Debora Olioso; Maurizio Brizzi; Paola Tononi; Mirco Cristofoletti; Paolo Bellavite
Journal:  BMC Complement Altern Med       Date:  2014-03-19       Impact factor: 3.659

8.  Amelioration of Cognitive Dysfunction in APP/PS1 Double Transgenic Mice by Long-Term Treatment of 4-O-Methylhonokiol.

Authors:  Yu-Yeon Jung; Young-Jung Lee; Dong-Young Choi; Jin Tae Hong
Journal:  Biomol Ther (Seoul)       Date:  2014-05       Impact factor: 4.634

9.  Evaluation of anxiolytic-like activity of Vitis vinifera juice in mice.

Authors:  Muhammad Aslam; Nuzhat Sultana
Journal:  Avicenna J Phytomed       Date:  2016 May-Jun

10.  Support for Natural Small-Molecule Phenols as Anxiolytics.

Authors:  Xiaohong Wang; Yahong Chen; Qiang Wang; Lu Sun; Guiyun Li; Chanxi Zhang; Jianmei Huang; Lei Chen; Haifeng Zhai
Journal:  Molecules       Date:  2017-12-06       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.